Myogenic properties of human mesenchymal stem cells derived from three different sources

Cell Transplantation

Volumn 21, Issue 1, 2012, Pages 153-173

  de la Garza Rodea, Anabel S ^a   van der Velde van Dijke, Ietje ^a   Boersma, Hester ^a   Gonçalves, Manuel A F V ^a   van Bekkum, Dirk W ^a   de Vries, Antoine A F ^a   Knaan Shanzer S ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell therapy; Mesenchymal stem cells (MSCs); Myogenic differentiation; NOD SCID mice; Skeletal muscle regeneration

Indexed keywords

BETA ACTIN; BETA GALACTOSIDASE; CARDIOTOXIN; DESMIN; DYSTROPHIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LENTIVIRUS VECTOR; MUSCLE PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOGENIC DIFFERENTATION 1 PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIC FACTOR 6; MYOGENIN; MYOSIN HEAVY CHAIN; SPECTRIN; SPECTRIN BETA SUBUNIT; TELOMERASE; TROPONIN I; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AGED; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL DIVISION; CELL FUSION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE INJURY; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; SYNOVIUM; TIBIALIS ANTERIOR MUSCLE; TISSUE DIFFERENTIATION;

ADIPOSE TISSUE; AGED; ANIMALS; BETA-GALACTOSIDASE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CELL TRANSPLANTATION; CELLS, CULTURED; DYSTROPHIN; FEMALE; GENE EXPRESSION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; SPECTRIN; SYNOVIAL MEMBRANE;

MAMMALIA; MURINAE; MUS;

EID: 80053623729     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X580554     Document Type: Article

References (88)

1. Ackema, K. B.; Charite, J. Mesenchymal stem cells from different organs are characterized by distinct topographic Hox codes. Stem Cells Dev. 17:979-1091; 2008.
2. Banfi, A.; Bianchi, G.; Notaro, R.; Luzzatto, L.; Cancedda, R.; Quarto, R. Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng. 8:901-910; 2002.
3. Baxter, M. A.; Wynn, R. F.; Jowitt, S. N.; Wraith, J. E.; Fairbairn, L. J.; Bellantuono, I. Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells 22:675-682; 2004.
4. Bianco, P.; Riminucci, M.; Gronthos, S.; Robey, P. G. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192; 2001.
5. Buhring, H. J.; Treml, S.; Cerabona, F.; de Zwart, P.; Kanz, L.; Sobiesiak, M. Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann. NY Acad. Sci. 1176:124-134; 2009.
6. Campagnoli, C.; Roberts, I. A. G.; Kumar, S.; Bennett, P. R.; Bellantuono, I.; Fisk, N. M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402; 2001.
7. Chan, J.; O'Donoghue, K.; Gavina, M.; Torrente, Y.; Kennea, N.; Mehmet, H.; Stewart, H.; Watt, D. J.; Morgan, J. E.; Fisk, N. M. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24: 1879-1891; 2006.
8. Chaturvedi, P.; Parnaik, V. K. Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10. PLoS One 5:e10620; 2010.
9. Cho, S. R.; Kim, Y. R.; Kang, H. S.; Yim, S. H.; Park, C.I.; Min, Y. H.; Lee, B. H.; Shin, J. C.; Lim, J. B. Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury. Cell Transplant. 18:1359-1368; 2009.
10. Cooper, R. N.; Thiesson, D.; Furling, D.; Di Santo, J. P.; Butler-Browne, G. S.; Mouly, V. Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation. Hum. Gene Ther. 14:1169-1179; 2003.
11. Copland, D. A.; Calder, C. J.; Raveney, B. J.; Nicholson, L. B.; Phillips, J.; Cherwinski, H.; Jenmalm, M.; Sedgwick, J. D.; Dick, A. D. Monoclonal antibody-mediated CD200 receptor signaling suppresses macrophage activation and tissue damage in experimental autoimmune uveoretinitis. Am. J. Pathol. 171:580-588; 2007.
12. Crisan, M.; Chen, C. W.; Corselli, M.; Andriolo, G.; Lazzari, L.; Peault, B. Perivascular multipotent progenitor cells in human organs. Ann. NY Acad. Sci. 1176:118-123; 2009.
13. Cristofalo, V. J.; Allen, R. G.; Pignolo, R. J.; Martin, B.G.; Beck, J. C. Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc. Natl. Acad. Sci. USA 95:10614-10619; 1998.
14. Cudré-Mauroux, C.; Occhiodoro, T.; König, S.; Salmon, P.; Bernheim, L.; Trono, D. Lentivector-mediated transfer of Bmi-1 and telomerase in muscle satellite cells yields a duchenne myoblast cell line with long-term genotypic and phenotypic stability. Hum. Gene Ther. 14:1525-1533; 2003.
15. Cui, C. H.; Uyama, T.; Miyado, K.; Terai, M.; Kyo, S.; Kiyono, T.; Umezawa, A. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell 18:1586-1594; 2007.
16. da Silva Meirelles, L.; Caplan, A. I.; Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299; 2008.
17. da Silva Meirelles, L.; Chagastelles, P. C.; Nardi, N. B. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119(Pt. 11):2204-2213; 2006.
18. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28: 875-884; 2000.
19. Deasy, B. M.; Lu, A.; Tebbets, J. C.; Feduska, J. M.; Schugar, R. C.; Pollett, J. B.; Sun, B.; Urish, K. L.; Gharaibeh, B. M.; Cao, B.; Rubin, R. T.; Huard, J. A role for cell sex in stem cell-mediated skeletal muscle regeneration: Female cells have higher muscle regeneration efficiency. J. Cell Biol. 177:73-86; 2007.
20. De Bari, C.; Dell'Accio, F.; Karystinou, A.; Guillot, P. V.; Fisk, N. M.; Jones, E. A.; McGonagle, D.; Khan, I. M.; Archer, C. W.; Mitsiadis, T. A.; Donaldson, A. N.; Luyten, F. P.; Pitzalis, C. A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum. 58:240-250; 2008.
21. De Bari, C.; Dell'Accio, F.; Tylzanowski, P.; Luyten, F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44:1928-1942; 2001.
22. De Bari, C.; Dell'Accio, F.; Vandenabeele, F.; Vermeesch, J. R.; Raymackers, J. M.; Luyten, F. P. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160:909-918; 2003.
23. de la Garza-Rodea, A. S.; van der Velde, I.; Boersma, H.; Goncalves, M. A. F.; van Bekkum, D. W.; de Vries, A.A. F.; Knaän-Shanzer, S. Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice. Cell Transplant. 20(2): 217-231; 2011.
24. Delorme, B.; Ringe, J.; Pontikoglou, C.; Gaillard, J.; Langonné, A.; Sensebé, L.; Noël, D.; Jorgensen, C.; H$áupl, T.; Charbord, P. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells 27:1142-1151; 2009.
25. Dezawa, M.; Ishikawa, H.; Itokazu, Y.; Yoshihara, T.; Hoshino, M.; Takeda, S.; Ide, C.; Nabeshima, Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309:314-317; 2005.
26. Djouad, F.; Bony, C.; Haupl, T.; Uzé, G.; Lahlou, N.; Louis-Plence, P.; Apparailly, F.; Canovas, F.; Rème, T.; Sany, J.; Jorgensen, C.; Noël, D. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res. Ther. 7:R1304-1315; 2005.
27. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
28. Erices, A.; Conget, P.; Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109:235-242; 2000.
29. Friedenstein, A. J.; Petrakova, K. V.; Kurolesova, A. I.; Frolova, G. P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247; 1968.
30. Gang, E. J.; Jeong, J. A.; Hong, S. H.; Hwang, S. H.; Kim, S. W.; Yang, I. H.; Ahn, C.; Han, H.; Kim, H. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22: 617-624; 2004.
31. Goncalves, M. A.; de Vries, A. A.; Holkers, M.; van de Watering, M. J. M.; van der Velde, I.; van Nierop, G. P.; Valerio, D.; Knaan-Shanzer, S. Human mesenchymal stem cells ectopically expressing full-lenght dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum. Mol. Genet. 15:213-221; 2006.
32. Goncalves, M. A.; Pau, M. G.; de Vries, A. A.; Valerio, D. Generation of a high-capacity hybrid vector: Packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited clon- ing capacity of adenoassociated virus vectors. Virology 288:236-246; 2001.
33. Gonçalves, M. A.; Swildens, J.; Holkers, M.; Narain, A.; van Nierop, G. P.; van de Watering, M. J.; Knan-Shanzer, S.; de Vries, A. A. Genetic complementation of human muscle cells via directed stem cell fusion. Mol. Ther. 16:741-748; 2008.
34. Gronthos, S.; Franklin, D. M.; Leddy, H. A.; Robey, P. G.; Storems, R. W.; Gimble, J. M. Surface protein characterization of human adipose tissue-derived stromal cells. J. Cell. Physiol. 189:54-63; 2001.
35. Gronthos, S.; Mankani, M.; Brahim, J.; Robey, P. G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 97:13625-13630; 2000.
36. Grünwald, J.; Mey, J.; Schnleben, W.; Hauss, J.; Hauss, W. H. Cultivated human arterial smooth muscle cells. The effect of donor age, blood pressure, diabetes and smoking on in vitro cell growth. Pathol. Biol. 31:819-823; 1983.
37. Hermann, M.; Pirkebner, D.; Draxl, A.; Berger, P.; Untergasser, G.; Margreiter, R.; Hengster, P. Dickkopf 3 is expressed in a subset of adult human pancreatic β cells. Histochem. Cell Biol. 127:513-521; 2007.
38. Hoshi, H.; McKeehan, W. L. Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In Vitro Cell Dev. Biol. 22:51-56; 1986.
39. Huang, H. I.; Chen, S. K.; Ling, Q. D.; Chien, C. C.; Liu, H. T.; Chan, S. H. Multilineage differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng. Part A 16:1491-1501; 2010.
40. In't Anker, P. S.; Noort, W. A.; Scherjon, S. A.; Kleijburg-van der Keur, C.; Kruisselbrink, A. B.; van Bezooijen, R. L.; Beekhuizen, W.; Willemze, R.; Kanhai, H. H.; Fibbe, W. E. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88:845-852; 2003.
41. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; de Groot-Swings, G. M.; Claas, F. H.; Fibbe, W. E.; Kanhai, H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345; 2004.
42. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; Noort, W. A.; Claas, F. H.; Willemze, R.; Fibbe, W. E.; Kanhai, H. H. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549; 2003.
43. Jeyapalan, J. C.; Sedivy, J. M. Cellular senescence and organismal aging. Mech. Ageing Dev. 129:467-474; 2008.
44. Jones, E. A.; English, A.; Kinsey, S. E.; Straszynski, L.; Emery, P.; Ponchel, F.; McGonagle, D. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow. Cytometry B Clin. Cytom. 70:391-399; 2006.
45. Karystinou, A.; Dell'Accio, F.; Kurth, T. B.; Wackerhage, H.; Khan, I. M.; Archer, C. W.; Jones, E. A.; Mitsiadis, T. A.; De Bari, C. Distinct mesenchymal progenitor cell subsets in the adult human synovium. Rheumatology 48: 1057-1064; 2009.
46. Klein, B.; Pastink, A.; Odijk, H.; Westerveld, A.; van der Eb, A. J. Transformation and immortalization of diploid xeroderma pigmentosum fibroblasts. Exp. Cell Res. 191: 256-262; 1990.
47. Knaan-Shanzer, S.; van de Watering, M. J.; van der Velde-van Dijke, I.; Goncalves, M. A.; Valerio, D.; de Vries, A. A. Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 23:1598-1607; 2005.
48. Knaan-Shanzer, S.; van der Velde-van Dijke, I.; van de Watering, M. J.; de Leeuw, P. J.; Valerio, D.; van Bekkum, D. W.; de Vries, A. A. Phenotypic and functional reversal within the early human hematopoietic compartment. Stem Cells 26:3210-3217; 2008.
49. Kopen, G. C.; Prockop, D. J.; Phinney, D. G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. USA 96:10711-10716; 1999.
50. Kuo, T. K.; Ho, J. H.; Lee, O. K. Mesenchymal stem cell therapy for nonmusculoskeletal diseases: Emerging applications. Cell Transplant. 18:1013-1028; 2009.
51. Kuznetsov, S. A.; Mankani, M. H.; Gronthos, S.; Satomura, K.; Bianco, P.; Robey, P. G. Circulating skeletal stem cells. J. Cell Biol. 153:1133-1140; 2001.
52. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringdén, O. Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586; 2008.
53. Lee, R. H.; Kim, B.; Choi, I.; Kim, H.; Choi, H. S.; Suh, K.; Bae, Y. C.; Jung, J. S. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell. Physiol. Biochem. 14: 311-324; 2004.
54. Liu, Y.; Yan, X.; Sun, Z.; Chen, B.; Han, Q.; Li, J.; Zhao, R. C. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev. 16:695-706; 2007.
55. Maier, A. B.; Westendorp, R. G. Relation between replicative senescence of human fibroblasts and life history characteristics. Ageing Res. Rev. 8:237-243; 2009.
56. Menicanin, D.; Bartold, P. M.; Zannettino, A. C.; Gronthos, S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev. 5:36-50; 2009.
57. Mochizuki, T.; Muneta, T.; Sakaguchi, Y.; Nimura, A.; Yokoyama, A.; Koga, H.; Sekiya, I. Higher chondrogenic potential of fibrous synovium- and adipose synovium- derived cells compared with subcutaneous fat-derived cells. Arthritis Rheum. 54:843-853; 2006.
58. Nunes, V. A.; Cavacana, N.; Canovas, M.; Strauss, B. E.; Zatz, M. Stem cells from umbilical cord blood differentiate into myotubes and express dystrophin in vitro only after exposure to in vivo muscle environment. Biol. Cell 99:185-196; 2007.
59. Petersen, B. E.; Bowen, W. C.; Patrene, K. D.; Mars, W. M.; Sullivan, A. K.; Murase, N.; Boggs, S. S.; Greenberger, J. S.; Goff, J. P. Bone marrow as a potential source of hepatic oval cells. Science 284:1168-1170; 1999.
60. Phinney, D. G.; Prockop, D. J. Concise review: Mesenchymal stem/multipotent stromal cells: The state of trans- differentiation and modes of tissue repair-current views. Stem Cells 25:2896-2902; 2007.
61. Pilz, G. A.; Ulrich, C.; Ruh, M.; Abele, H.; Schafer, R.; Kluba, T.; Buhring, H. J.; Rolauffs, B.; Aicher, W. K. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone mar- row-derived mesenchymal stromal cells. Stem Cells Dev. 20(4):635-646; 2011.
62. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
63. Pittenger, M. F.; Martin, B. J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95: 9-20; 2004.
64. Rada, T.; Reis, R. L.; Gomes, M. E. Distinct stem cells subpopulations isolated from human adipose tissue exhibit different chondrogenic and osteogenic differentiation potential. Stem Cell Rev. 7(1):64-76; 2011.
65. Riekstina, U.; Cakstina, I.; Parfejevs, V.; Hoogduijn, M.; Jankovskis, G.; Muiznieks, I.; Muceniece, R.; Ancans, J. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 5:378-386; 2009.
66. Rodriguez, A. M.; Pisani, D.; Dechesne, C. A.; Turc-Carel, C.; Kurzenne, J. Y.; Wdziekonski, B.; Villageois, A.; Bagnis, C.; Breittmayer, J. P.; Groux, H.; Ailhaud, G.; Dani, C. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med. 201: 1397-1405; 2005.
67. Roubelakis, M. G.; Pappa, K. I.; Bitsika, V.; Zagoura, D.; Vlahou, A.; Papadaki, H. A.; Antsaklis, A.; Anagnou, N. P. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: Comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 16:931-952; 2007.
68. Russell, K. C.; Phinney, D. G.; Lacey, M. R.; Barrilleaux, B.L.; Meyertholen, K. E.; O'Connor, K. C. In vitro high- capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28: 788-798; 2010.
69. Sabatini, F.; Petecchia, L.; Tavian, M.; Jodon de Villeroche, V.; Rossi, G. A.; Brouty-Boye, D. Human bronchial fibro- blasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab. Invest. 85: 962-971; 2005.
70. Sacchetti, B.; Funari, A.; Michienzi, S.; Di Cesare, S.; Piersanti, S.; Saggio, I.; Tagliafico, E.; Ferrari, S.; Robey, P. G.; Riminucci, M.; Bianco, P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131:324-336; 2007.
71. Sakaguchi, Y.; Sekiya, I.; Yagishita, K.; Muneta, T. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum. 52:2521-2529; 2005.
72. Santa Maria, L.; Rojas, C. V.; Minguell, J. J. Signals from damaged but not undamaged skeletal muscle induce myogenic differentiation of rat bone-marrow-derived mesenchymal stem cells. Exp. Cell Res. 300:418-426; 2004.
73. Satija, N. K.; Singh, V. K.; Verma, Y. K.; Gupta, P.; Sharma, S.; Afrin, F.; Sharma, M.; Sharma, P.; Tripathi, R. P.; Gurudutta, G. U. Mesenchymal stem cell-based therapy: A new paradigm in regenerative medicine. J. Cell. Mol. Med. 13:4385-4402; 2009.
74. Seshi, B.; Kumar, S.; King, D. Multilineage gene expression in human bone marrow stromal cells as evidenced by single-cell microarray analysis. Blood Cells Mol. Dis. 31: 268-285; 2003.
75. Shi, D.; Reinecke, H.; Murry, C. E.; Torok-Storb, B. Myogenic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood 104:290-294; 2004.
76. Shibata, K. R.; Aoyama, T.; Shima, Y.; Fukiage, K.; Otsuka, S.; Furu, M.; Kohno, Y.; Ito, K.; Fujibayashi, S.; Neo, M.; Nakayama, T.; Nakamura, T.; Toguchida, J. Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25:2371-2382; 2007.
77. Sobiesiak, M.; Sivasubramaniyan, K.; Hermann, C.; Tan, C.; Orgel, M.; Treml, S.; Cerabona, F.; Dezwart, P.; Ochs, U.; Müller, C. A.; Gargett, C. E.; Kalbacher, H.; Bühring, H. J. The mesenchymal stem cell antigen msca-1 is identical to tissue non-specific alkaline phosphatase. Stem Cells Dev. 5:378-386; 2009.
78. Sorrentino, A.; Ferracin, M.; Castelli, G.; Biffoni, M.; Tomaselli, G.; Baiocchi, M.; Fatica, A.; Negrini, M.; Peschle, C.; Valtieri, M. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol. 36:1035-1046; 2008.
79. Stenderup, K.; Justesen, J.; Clausen, C.; Kassem, M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926; 2003.
80. Stumpfova, M.; Ratner, D.; Desciak, E. B.; Eliezri, Y. D.; Owens, D. M. The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma. Cancer Res. 70:2962-2972; 2010.
81. van Tuyn, J.; Knaan-Shanzer, S.; van de Watering, M. J.; de Graaf, M.; van der Laarse, A.; Schalij, M. J.; van der Wall, E. E.; de Vries, A. A.; Atsma, D. E. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc. Res. 67:245-255; 2005.
82. Wakitani, S.; Saito, T.; Caplan, A. I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426; 1995.
83. Wang, L.; Liu, J. Q.; Talebian, F.; El-Omrani, H. Y.; Khattabi, M.; Yu, L.; Bai, X. F. Tumor expression of CD200 inhibits IL-10 production by tumor-associated myeloid cells and prevents tumor immune evasion of CTL therapy. Eur. J. Immunol. 40:2569-2579; 2010.
84. Williams, J. T.; Southerland, S. S.; Souza, J.; Calcutt, A. F.; Cartledge, R. G. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am. Surg. 65:22-26; 1999.
85. Yoshimura, H.; Muneta, T.; Nimura, A.; Yokoyama, A.; Koga, H.; Sekiya, I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 327:449-462; 2007.
86. Zhu, C. H.; Mouly, V.; Cooper, R. N.; Mamchaoui, K.; Bigot, A.; Shay, J. W.; Di Santo, J. P.; Butler-Browne, G.S.; Wright, W. E. Cellular senescence in human myoblasts is overcome by human telomerase reverse transcriptase and cyclindependent kinase 4: Consequences in aging muscle and therapeutic strategies for muscular dystrophies. Aging Cell 6:515-523; 2007.
87. Zimmermann, S.; Voss, M.; Kaiser, S.; Kapp, U.; Waller, C.F.; Martens, U. M. Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17:1146-1149; 2003.
88. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7:211-228; 2001.